Vitiligo in an urban academic setting

International Journal of Dermatology

Volumn 49, Issue 1, 2010, Pages 39-43

  Paravar, Taraneh ^a   Lee, Delphine J ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBODY; ANTINUCLEAR ANTIBODY; CARDIOLIPIN ANTIBODY; CENTROMERE ANTIBODY; MICROSOME ANTIBODY; MITOCHONDRION ANTIBODY; SJOGREN SYNDROME A ANTIBODY; SMOOTH MUSCLE ANTIBODY; THYROGLOBULIN ANTIBODY; THYROID ANTIBODY; UNCLASSIFIED DRUG;

ADOLESCENT; ADULT; AGE DISTRIBUTION; ANTIBODY DETECTION; ARTICLE; CHILD; COMORBIDITY; DISEASE DURATION; EPIDEMIOLOGICAL DATA; FEMALE; HUMAN; HYPOTHYROIDISM; MALE; ONSET AGE; POPULATION RESEARCH; SCHOOL CHILD; THYROID DISEASE; URBAN AREA; VITILIGO;

ACADEMIC MEDICAL CENTERS; ADOLESCENT; ADULT; AGE OF ONSET; AGED; AGED, 80 AND OVER; ANTIBODIES, ANTINUCLEAR; CHILD; CHILD, PRESCHOOL; COMORBIDITY; FEMALE; HUMANS; HYPOTHYROIDISM; IODIDE PEROXIDASE; LOS ANGELES; MALE; MIDDLE AGED; RETROSPECTIVE STUDIES; SEROEPIDEMIOLOGIC STUDIES; URBAN POPULATION; VITILIGO; YOUNG ADULT;

EID: 73149107431     PISSN: 00119059     EISSN: 13654632     Source Type: Journal    
DOI: 10.1111/j.1365-4632.2009.04175.x     Document Type: Article

References (27)

1. Alkhateeb A, Fain PR, Thody A. Epidemiology of vitiligo and associated autoimmune diseases in Caucasian probands and their families. Pigment Cell Res 2003, 16:208-214.
2. Lu T, Gao T, Wang A. Vitiligo prevalence study in Shaanxi Province, China. Int J Dermatol 2007, 46:47-51.
3. Schallreuter KU, Bahadoran P, Picardo M. Vitiligo pathogenesis: autoimmune disease, genetic defect, excessive reactive oxygen species, calcium imbalance, or what else? Exp Dermatol 2008, 17:139-140.
4. Grimes PE. White patches and bruised souls: advances in the pathogenesis and treatment of vitiligo. J Am Acad Dermatol 2004, 51:S5-S7.
5. Gopal KV, Rama Rao GR, Kumar YH. Vitiligo: a part of a systemic autoimmune process. Indian J Dermatol Venereol Leprol 2007, 73:162-165.
6. Sehgal VN, Srivastava G. Vitiligo: auto-immunity and immune responses. Int J Dermatol 2006, 45:583-590.
7. Sehgal VN, Srivastava G. Vitiligo: compendium of clinico-epidemiological features. Indian J Dermatol Venereol Leprol 2007, 73:149-156.
8. Liu JB, Li M, Yang S. Clinical profiles of vitiligo in China: an analysis of 3742 patients. Clin Exp Dermatol 2005, 30:327-331.
9. Zhang XJ, Liu JB, Gui JP. Characteristics of genetic epidemiology and genetic models for vitiligo. J Am Acad Dermatol 2004, 51:383-390.
10. Horio T. Indications and action mechanisms of phototherapy. J Dermatol Sci 2000, 23(Suppl. 1):S17-S21.
11. Wu CS, Yu CL, Wu CS. Narrow-band ultraviolet-B stimulates proliferation and migration of cultured melanocytes. Exp Dermatol 2004, 13:755-763.
12. Handa S, Dogra S. Epidemiology of childhood vitiligo: a study of 625 patients from north India. Pediatr Dermatol 2003, 20:207-210.
13. Hu Z, Liu JB, Ma SS. Profile of childhood vitiligo in China: an analysis of 541 patients. Pediatr Dermatol 2006, 23:114-116.
14. Dogra S, Parsad D, Handa S. Late onset vitiligo: a study of 182 patients. Int J Dermatol 2005, 44:193-196.
15. Daneshpazhooh M, Mostofizadeh GM, Behjati J. Anti-thyroid peroxidase antibody and vitiligo: a controlled study. BMC Dermatol 2006, 6:3.
16. Mandry RC, Ortiz LJ, Lugo-Somolinos A. Organ-specific autoantibodies in vitiligo patients and their relatives. Int J Dermatol 1996, 35:18-21.
17. Kurtev A, Dourmishev AL. Thyroid function and autoimmunity in children and adolescents with vitiligo. J Eur Acad Dermatol Venereol 2004, 18:109-111.
18. Prcic S, Djuran V, Mikov A. Vitiligo in children. Pediatr Dermatol 2007, 24:666.
19. Farrokhi S, Hojjat-Farsangi M, Noohpisheh MK. Assessment of the immune system in 55 Iranian patients with vitiligo. J Eur Acad Dermatol Venereol 2005, 19:706-711.
20. Grimes PE, Halder RM, Jones C. Autoantibodies and their clinical significance in a black vitiligo population. Arch Dermatol 1983, 119:300-303.
21. Hann SK, Im S, Kim HI. Increased incidence of antismooth muscle antibody in Korean vitiligo patients. J Dermatol 1993, 20:679-683.
22. Zettinig G, Tanew A, Fischer G. Autoimmune diseases in vitiligo: do anti-nuclear antibodies decrease thyroid volume ? Clin Exp Immunol 2003, 131:347-354.
23. Cho S, Kang HC, Hahm JH. Characteristics of vitiligo in Korean children. Pediatr Dermatol 2000, 17:189-193.
24. Korkij W, Soltani K, Simjee S. Tissue-specific autoantibodies and autoimmune disorders in vitiligo and alopecia areata: a retrospective study. J Cutan Pathol 1984, 11:522-530.
25. Birlea SA, Fain PR, Spritz RA. A Romanian population isolate with high frequency of vitiligo and associated autoimmune diseases. Arch Dermatol 2008, 144:310-316.
26. Jacobson DL, Gange SJ, Rose NR. Epidemiology and estimated population burden of selected autoimmune diseases in the United States. Clin Immunol Immunopathol 1997, 84:223-243.
27. Health, United States, 2007, With Chartbook on Trends in the Health of Americans 2007, 248-290. Hyattsville, MD, National Center for Health Statistics